Sunday, November 8, 2026

USD/CHF Went Down By Over 1% In The Last 24 Hours

USD/CHF Went Down By Over 1% In The Last 24 Hours

(VIANEWS) - USD/CHF (USDCHF) has been up by 1.2436% for the last session's close. At 17:06 EST on Wednesday, 17 July, USD/CHF (USDCHF) is $0.88.

USD/CHF (USDCHF) Range

Concerning USD/CHF's daily highs and lows, it's 1.187% down from its trailing 24 hours low of $0.89 and 1.264% down from its trailing 24 hours high of $0.89.

USD/CHF's yearly highs and lows, it's 5.966% up from its 52-week low and 4.501% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/CHF's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 16 July, "A return to trading within the ascending channel would likely improve sentiment for the USD/JPY pair, with a potential target toward the upper boundary of the ascending channel near 163.70.", "On the downside, the USD/JPY pair could find key support around the psychological level of 158.00. "
  • According to FXStreet on Monday, 15 July, "A return to trading within the ascending channel would likely improve sentiment for the USD/JPY pair, with a potential target toward the upper boundary of the ascending channel near 163.50."
  • Usd/jpy price analysis: struggles below 158.00 after intervention, eyes further decline. According to FXStreet on Monday, 15 July, "Although the USD/JPY price action remains above the Ichimoku Cloud (Kumo), indicating that the uptrend remains intact, the pair trades below the Tenkan and Kijun-Sen, breaching the Senkou Span A previous support turning resistance.", "The USD/JPY trades had minimal losses of 0.02%, yet they recovered some ground late in the North American session. "
  • Usd/jpy price analysis: struggles to crack 158.50 as bearish signals mount. According to FXStreet on Tuesday, 16 July, "More technical signals suggest the USD/JPY is turning neutral-bearishly biased, with price diving below the Tenkan and Kijun-Sen, showing the lack of buyers in the market. ", "The USD/JPY edged higher during Tuesday's North American session, registering minuscule gains of 0.24% and trading below the 158.50 figure. "
  • Usd/jpy extends upside near 158.50 despite strong Japan’s tankan index. According to FXStreet on Wednesday, 17 July, "The USD/JPY pair extends gains near 158.40 on the selling pressure around the Japanese currency during the early Asian session on Wednesday. "

More news about USD/CHF (USDCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com